A comparison of the level of MBP-hydrolyzing activity in autoimmune and mental disorders showed that the percentage of antibodies with pronounced activity decreases in the following series: MS (84%) < schizophrenia (69%) < BAR (52%) [34,37]. The gene discussed is MBP; the disease is psychiatric disorder.